SenesTech Inc
$ 2.26
-2.59%
29 Dec - close price
- Market Cap 12,117,400 USD
- Current Price $ 2.26
- High / Low $ 2.36 / 2.15
- Stock P/E N/A
- Book Value 2.17
- EPS -2.21
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.38 %
- ROE -0.78 %
- 52 Week High 6.24
- 52 Week Low 1.30
About
SenesTech, Inc. is a pioneering biotechnology company headquartered in Phoenix, Arizona, focused on revolutionizing pest management through innovative fertility control technologies. By providing environmentally sustainable alternatives to conventional pest control, SenesTech tackles significant challenges in both agricultural and urban pest populations, highlighting its commitment to ecological sustainability. The company’s flagship product not only sets a precedent in humane pest control but also positions SenesTech as a leader in the growing market for sustainable solutions. With its emphasis on technological advancement and ecological stewardship, SenesTech is strategically positioned for growth in an increasingly environmentally conscious marketplace.
Analyst Target Price
$10.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-11 | 2025-08-07 | 2025-05-07 | 2025-03-12 | 2024-11-12 | 2024-08-08 | 2024-05-09 | 2024-02-21 | 2023-11-09 | 2023-08-10 | 2023-05-11 | 2023-03-16 |
| Reported EPS | -0.28 | -0.87 | -1.2808 | -1.22 | -2.07 | -3.08 | -0.36 | -0.9 | -0.47 | -0.7 | -1.32 | -3.21 |
| Estimated EPS | -0.35 | None | None | -1.5 | -3.2 | -3.2 | -0.34 | -0.44 | -0.85 | -0.78 | -0.81 | -4.2 |
| Surprise | 0.07 | 0 | 0 | 0.28 | 1.13 | 0.12 | -0.02 | -0.46 | 0.38 | 0.08 | -0.51 | 0.99 |
| Surprise Percentage | 20% | None% | None% | 18.6667% | 35.3125% | 3.75% | -5.8824% | -104.5455% | 44.7059% | 10.2564% | -62.963% | 23.5714% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SNES
2025-11-15 14:08:59
SenesTech (NASDAQ: SNES) will report its third quarter 2025 financial results on Monday, November 10, 2025, after market close. The company will also host a conference call at 5:00 p.m. Eastern time on the same day to discuss the results. Interested parties can access the live webcast via the Investor Relations section of SenesTech's website.
2025-11-12 15:09:02
SenesTech (SNES) announced record revenue and improved adjusted EBITDA in its Q3 2025 financial results, driven by strong growth in its Evolve® Rodent Birth Control™ products. Revenue increased by 43% year-over-year to $690,000, with Evolve® sales comprising 85% of total revenue. The company also saw significant channel expansion and maintains a robust cash position as it pursues profitable growth.
2025-11-10 17:00:00
SenesTech, Inc. announced record financial results for Q3 2025, with revenues climbing 43% to $690,000, largely driven by a 77% increase in Evolve® Rodent Birth Control™ product sales. The company also achieved a record low Adjusted EBITDA loss of $1.2 million and reported a robust cash balance of $10.2 million, positioning it for continued growth and progress towards profitability. This success is attributed to a multi-channel distribution strategy across e-commerce, municipal, retail, and pest management professional segments.
2025-11-10 04:41:31
SenesTech, Inc. (SNES) reported record Q3 revenues of $690,000, a 43% year-over-year increase, primarily driven by its Evolve product line with e-commerce sales now representing over 50% of total revenue. Despite a decline in ContraPest sales, the company achieved its best-ever adjusted EBITDA loss of $1.2 million. While showing strong liquidity, the company faces profitability challenges and a high Altman Z-Score indicating financial distress risk.
2025-11-10 04:41:31
SenesTech Inc (SNES) reported record Q3 2025 revenues of $690,000, a 43% year-over-year increase, driven by e-commerce and retail expansion. Despite achieving its lowest adjusted EBITDA loss of $1.2 million, the company faces challenges including a lawsuit from a competitor and pending international approvals. Discussions are underway for expanding into Lowe's brick-and-mortar stores.
2025-11-10 04:41:31
SenesTech announced that its Evolve® Rat Birth Control® is now available online at Lowes.com, providing access to millions of homeowners through one of the largest home improvement retailers. This online launch is seen as a major step toward potential in-store expansion, leveraging Lowe's 1,700 stores and $11 billion in online sales. The product offers a non-poison, humane solution for rat population control, focusing on reducing reproduction rather than lethal methods, which the company expects will drive significant growth and visibility.
